Chong C. Chua is a hematologist oncologist based in Heidelberg, VIC. His practice address is 145 Studley Road, Heidelberg, VIC 3084, Australia. He looks after people who need help with blood conditions, and conditions that affect blood-making tissues.
In many cases, that means working with diagnoses such as leukaemias and related blood cancers. This can include Acute Myeloid Leukaemia (AML), Chronic B-Cell Leukaemia (CBCL), and Chronic Lymphocytic Leukaemia (CLL). He also treats Myelodysplastic Syndrome (MDS), Myelofibrosis, and Essential Thrombocythaemia. For some patients, the main issue is low or changing blood counts, which can affect energy levels, infections, bleeding, or bruising.
Chua also supports people with other blood and lymph conditions, including Small Lymphocytic Lymphoma (SLL) and Leukocytosis. At times, symptoms can develop slowly, and other times they come on more quickly. Part of the job is making sense of test results, then talking through what the options might be.
Blood issues can also link to clotting problems. He manages conditions like Deep Vein Thrombosis and broader Venous Thromboembolism (VTE). He also looks after patients with Mesenteric Venous Thrombosis, which is a clot in the bowel area. When clotting is involved, timing matters, and treatment plans usually need to be clear and closely followed.
In day-to-day care, he works with patients who are dealing with ongoing treatment needs or changes in symptoms over time. That can mean review visits, planning next steps, and adjusting care as test results come in. It’s not always one straight path, and many people need support to get through the uncertainty.
Experience: specific years of experience are not listed here. Education: education details are not provided in the information available. Research and clinical trials: no specific publications, research, or clinical trial details are listed here.
If you’re looking for a hematology and oncology clinician in the Heidelberg area, Chong C. Chua provides care for a mix of leukaemias, lymph conditions, and clotting-related problems, including AML, CLL, MDS, myelofibrosis, and VTE.